Paroxetine Mesylate: Multi-Target SSRI and Kinase Inhibitor
2026-06-30
Paroxetine Mesylate is a selective serotonin reuptake inhibitor with high-affinity SERT inhibition and potent multi-kinase activity. Its verified actions include MET and ERBB3 kinase inhibition and significant anti-colorectal cancer effects in vitro and in vivo. This dossier details mechanisms, benchmarks, and protocol considerations for translational research.
ERAD-Hijacking Chimeras Enable Targeted Degradation of TM Pr
2026-06-29
Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule-based platform that selectively degrades transmembrane proteins by hijacking endoplasmic reticulum-associated degradation (ERAD). This approach overcomes major limitations of existing targeted protein degradation methods, showing high efficacy against challenging membrane targets and expanding opportunities for therapeutic and research applications.
Breast Cancer’s Reliance on MCL-1: Apoptosis as the Key Func
2026-06-29
The referenced study clarifies that breast cancer cell survival is fundamentally dependent on the canonical anti-apoptotic function of MCL-1, rather than its non-apoptotic roles. This finding has practical implications for designing targeted therapies and experimental models using selective MCL-1 inhibitors for apoptosis induction in cancer cells.
Machine Learning Discovery of Novel Senolytics: Implications
2026-06-28
The referenced study demonstrates that machine learning can effectively identify new senolytic compounds by leveraging diverse, published datasets. This approach reduces screening costs and expands the chemical space for targeting cellular senescence, with direct relevance for cancer biology and advanced assay development.
Hydroxytyrosol’s Antioxidant Power: Redefining CKD and Cardi
2026-06-27
Explore how Hydroxytyrosol, a phenolic antioxidant compound, uniquely addresses oxidative stress and inflammation in chronic kidney and cardiovascular research. Discover advanced mechanistic insights and protocol guidance not covered in standard reviews.
Capsaicin in Pain and Inflammation: Protocols & Practical In
2026-06-26
Capsaicin ((E)-Capsaicin) is a dual-action research tool that enables precise modulation of TRPV1 ion channels and KDM1A/LSD1 epigenetic targets. This article unpacks validated experimental workflows, advanced troubleshooting, and actionable insights for pain, inflammation, and cancer research—empowering reliable, reproducible results using APExBIO's high-purity capsaicin.
Paroxetine Mesylate: Applied SSRI Research & Oncology Workfl
2026-06-26
Paroxetine Mesylate bridges neuropsychiatric and oncology research through its robust SSRI function and multi-kinase inhibitory profile. This article explores practical workflows, protocol optimizations, and troubleshooting strategies that capitalize on its unique molecular mechanisms, offering actionable guidance for translational and bench scientists.
PP 2 (AG 1879): Reliable Src Kinase Inhibition for Cell Assa
2026-06-25
This article guides biomedical researchers and lab technicians through real-world challenges in cell viability and signaling assays, focusing on how PP 2 (AG 1879) (SKU A8216) addresses reproducibility, selectivity, and workflow needs. Backed by quantitative data and recent literature, it provides actionable insights for optimizing experimental outcomes using this selective Src kinase inhibitor.
Transcription Condensate Dynamics Safeguard Genome Stability
2026-06-25
This study elucidates how the formation and dissolution of transcription condensates at histone locus bodies, regulated by specific kinases, coordinate linker histone expression with DNA replication to maintain genome integrity. The findings offer mechanistic insight into nuclear organization during the cell cycle and highlight new avenues for targeting transcriptional dysregulation in cancer research.
GTP Solution in mRNA Synthesis: Applied Workflows & Optimiza
2026-06-24
High-purity GTP Solution (100 mM) is essential for reliable in vitro transcription of therapeutic mRNA, enabling robust, contamination-free synthesis for advanced applications like localized p21 mRNA-LNP therapies. Learn how experimental workflows leverage its precision, troubleshoot common pitfalls, and maximize translational impact in RNA-based research.
Disodium Bicinchoninate: Water-Soluble Advancements for Mole
2026-06-23
Disodium bicinchoninate, a highly water-soluble small molecule reagent, enables robust and interference-free biochemical workflows where conventional organic-soluble chelators fail. Its unique solubility profile and stability make it a premier choice for reproducible molecular biology assays and advanced chelation-based applications.
AMG 9810: TRPV1 Antagonist Workflows for Pain & Sensory Rese
2026-06-23
AMG 9810 empowers researchers with reliable, high-affinity TRPV1 antagonism, unlocking precise studies of pain mechanisms and sensory neuron signaling. This guide distills advanced use-cases, actionable protocols, and troubleshooting insights to maximize experimental success and reproducibility.
Sabutoclax: Pan-Bcl-2 Inhibitor Advancing Apoptosis Assays
2026-06-22
Sabutoclax stands out as a potent pan-Bcl-2 inhibitor with high cell permeability, enabling precise and reproducible apoptosis induction in cancer research. With robust data in both in vitro and in vivo models, it empowers researchers to dissect anti-apoptotic signaling and optimize experimental workflows targeting apoptosis resistance.
G418 Sulfate (Geneticin): Selection, Mechanism & Antiviral U
2026-06-22
G418 Sulfate (Geneticin) is a high-purity aminoglycoside antibiotic widely used in genetic engineering as a selection agent and in antiviral research, notably inhibiting Dengue virus serotype 2. Its primary mechanism involves ribosomal protein synthesis inhibition, enabling precise genetic selection and expanded antiviral applications.
Tamoxifen’s Translational Impact: Mechanistic Mastery to Str
2026-06-21
This thought-leadership article dissects how tamoxifen’s multifaceted mechanisms and robust experimental validation position it as a cornerstone for both breast cancer research and advanced gene knockout strategies. Drawing on recent breakthroughs and the evolving landscape of endocrine resistance, we synthesize mechanistic insights, competitive context, and practical protocol guidance—empowering translational researchers to optimize experimental design and anticipate future clinical shifts.
467 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page